The Current Ratio as of September 2024 (TTM) for Aridis Pharmaceuticals, Inc. (ARDS) is 0.37

According to Aridis Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.37. This represents a change of 40.43% compared to the average of 0.27 of the last 4 quarters.

Aridis Pharmaceuticals, Inc. (ARDS) Historical Current Ratio (quarterly & annually)

How has ARDS Current Ratio performed in the past?

The mean historical Current Ratio of Aridis Pharmaceuticals, Inc. over the last ten years is 3.59. The current 0.37 Current Ratio has changed 940.40% with respect to the historical average. Over the past ten years (40 quarters), ARDS's Current Ratio was at its highest in in the December 2017 quarter at 7.98. The Current Ratio was at its lowest in in the March 2017 quarter at 0.

Aridis Pharmaceuticals, Inc. (ARDS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Aridis Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aridis Pharmaceuticals, Inc. (ARDS) Average Current Ratio

How has ARDS Current Ratio performed in the past?

The current Current Ratio of Aridis Pharmaceuticals, Inc. (ARDS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Aridis Pharmaceuticals, Inc. (ARDS) Current Ratio vs. Peers

How is ARDS’s Current Ratio compared to its peers?

Aridis Pharmaceuticals, Inc.’s Current Ratio is less than Akari Therapeutics, Plc (0.58), greater than Aditxt, Inc. (0.07), greater than ABVC BioPharma, Inc. (0.33), less than Acasti Pharma Inc. (7.86), less than Sigilon Therapeutics, Inc. (1.78), less than Reviva Pharmaceuticals Holdings, Inc. (0.41), greater than ZyVersa Therapeutics, Inc. (0.06), greater than Kiromic BioPharma, Inc. (0.35), less than Unicycive Therapeutics, Inc. (3.37), less than Avenue Therapeutics, Inc. (4.30), less than Hoth Therapeutics, Inc. (14.62), less than Revelation Biosciences, Inc. (1.10), less than NeuroBo Pharmaceuticals, Inc. (2.94), less than Virax Biolabs Group Limited (25.94), less than Reviva Pharmaceuticals Holdings, Inc. (0.41), less than Eyenovia, Inc. (0.43), less than Cognition Therapeutics, Inc. (3.07), less than TransCode Therapeutics, Inc. (1.25), less than Kodiak Sciences Inc. (10.59), less than Dermata Therapeutics, Inc. (2.73),

Build a custom stock screener for Aridis Pharmaceuticals, Inc. (ARDS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aridis Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aridis Pharmaceuticals, Inc. (ARDS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aridis Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.